Ropinirole is indicated for the treatment of the following conditions:

• Parkinson's disease: It is used to manage the signs and symptoms of Parkinson's disease, including tremors, stiffness, and slowed movement.
• Restless Legs Syndrome (RLS): Ropinirole is also approved for the treatment of moderate to severe primary RLS, a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations.

• Ropinirole Tablets can be taken with or without food
• Retitration of Ropinirole may be warranted if therapy is interrupted

Parkinson’s Disease: 

• The recommended starting dose is 0.25 mg taken three times daily; titrate to a maximum daily dose of 24 mg 
• Renal Impairment: The maximum recommended dose is 18 mg/day in patients with end-stage renal disease on hemodialysis

Restless Legs Syndrome: 

• The recommended starting dose is 0.25 mg once daily, 1 to 3 hours before bedtime, titrate to a maximum recommended dose of 4 mg daily 
• Renal Impairment: The maximum recommended dose is 3 mg/day in patients with end-stage renal disease on hemodialysis 

Side effects associated with Ropinirole include-

• Nausea
• Dizziness
• Somnolence (excessive sleepiness)
• Fatigue
• Orthostatic hypotension (low blood pressure upon standing)
• Dyskinesia (abnormal involuntary movements)
• Insomnia
• Constipation
• Hallucinations
• Peripheral edema (swelling of the limbs)

Nausea	Dizziness	Somnolence	Fatigue
Orthostatic Hypotension	Dyskinesia	Insomnia (Difficulty in Falling asleep)	Constipation

• Sudden onset of sleep and somnolence may occur
• Syncope may occur
• Hypotension, including orthostatic hypotension may occur
• May cause hallucinations and psychotic-like behaviors
• May cause or exacerbate dyskinesia
• May cause problems with impulse control or compulsive behaviors